Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

por Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Moinnudin, Asif, Al Anezi, Khalid, Al Hashmi, Hani
Publicado 2021